• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.

    Edison Oncology Finishes Phase 1/2A Orotecan(TM) Trial Enrollment

    ACCESSWIRE BIO

    Edison Oncology To Showcase Two Posters At 2026 AACR Meeting

    ACCESSWIRE

    Edison Oncology Unveils Data On EO1001 And EO?4426

    ACCESSWIRE

    Edison Oncology Present 2 Posters At AACR-NCI-EORTC Conference

    ACCESSWIRE

    Edison Reports Promising Interim Data from Ongoing Orotecan® Clinical Trial

    PR NEWSWIRE

    Edison Oncology Announces Presentation of Two Scientific Posters at AACR Meeting

    PR NEWSWIRE

    Edison Oncology Partners DNA-damage Response Inhibitor Program with Rakovina

    PRNEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.